Hyperbaric Oxygen Treatment Improves Hearing Level via Attenuating TLR4/NF- κB Mediated Inflammation in Sudden Sensorineural Hearing Loss Patients.
Conclusion: HBOT alleviates hearing loss in ISSHL patients by suppressing the inflammatory response induced by TLR4 and NF-κB signaling.
PMID: 32553077 [PubMed - in process]
Source: Biomedical and Environmental Sciences : BES - Category: Biomedical Science Authors: Liu XH, Liang F, Jia XY, Zhao L, Zhou Y, Yang J Tags: Biomed Environ Sci Source Type: research
More News: Audiometry | Biomedical Science | Environmental Health | Hyperbaric Oxygen Therapy | Study